Hims & Hers Health Inc Ordinary Shares - Class A HIMS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if HIMS is a good fit for your portfolio.
News
-
Hims & Hers to Announce First Quarter 2024 Financial Results on May 6, 2024
-
Hims & Hers Appoints Christopher Payne, Seasoned Tech Industry Executive, as Newest Board Member
-
Hims & Hers to Participate in Canaccord Genuity's Virtual eCommerce Sustainable Advantage Forum on March 14, 2024
-
Thinking about buying stock in Infobird, PubMatic, Hims & Hers Health, FibroGen, or Alpha Metallurgical Resources?
-
Hims & Hers' stock jumps on hopes of a first profitable year, as it floats opportunities in weight loss
-
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
-
Hims & Hers Names Dan Kenger as the Company’s First Chief Design Officer
-
Hims & Hers to Announce Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024
Trading Information
- Previous Close Price
- $12.53
- Day Range
- $12.19–12.62
- 52-Week Range
- $5.67–17.16
- Bid/Ask
- $12.41 / $12.44
- Market Cap
- $2.66 Bil
- Volume/Avg
- 719,641 / 5.2 Mil
Key Statistics
- Price/Earnings (Normalized)
- 88.88
- Price/Sales
- 3.01
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 0.07%
Company Profile
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Stock Style Box
- Small Growth
- Total Number of Employees
- 1,046
- Website
- https://www.forhims.com
Comparables
Valuation
Metric
|
HIMS
|
NUTX
|
GDRX
|
---|---|---|---|
Price/Earnings (Normalized) | 88.88 | 2.80 | 23.85 |
Price/Book Value | 7.78 | 0.44 | 3.67 |
Price/Sales | 3.01 | 0.11 | 3.88 |
Price/Cash Flow | 49.81 | 9.14 | 18.18 |
Price/Earnings
HIMS
NUTX
GDRX
Financial Strength
Metric
|
HIMS
|
NUTX
|
GDRX
|
---|---|---|---|
Quick Ratio | 2.56 | 1.45 | 6.79 |
Current Ratio | 3.00 | 1.56 | 7.12 |
Interest Coverage | — | −1.97 | −0.55 |
Quick Ratio
HIMS
NUTX
GDRX
Profitability
Metric
|
HIMS
|
NUTX
|
GDRX
|
---|---|---|---|
Return on Assets (Normalized) | 7.29% | 2.84% | 6.98% |
Return on Equity (Normalized) | 8.97% | 14.31% | 13.70% |
Return on Invested Capital (Normalized) | 8.80% | 6.88% | 8.64% |
Return on Assets
HIMS
NUTX
GDRX
Household & Personal Products Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
PG
| Procter & Gamble Co | Gpdtgwgdmr | Mdmr | $385.2 Bil | |
UL
| Unilever PLC ADR | Wbpgcvmwb | Ldj | $130.3 Bil | |
CL
| Colgate-Palmolive Co | Szxgcdzv | Tpnj | $75.4 Bil | |
EL
| The Estee Lauder Companies Inc Class A | Rjqykvrdf | Clr | $52.6 Bil | |
KMB
| Kimberly-Clark Corp | Dkxtcprcl | Tmvgz | $46.0 Bil | |
RBGLY
| Reckitt Benckiser Group PLC ADR | Tsfzzcvkb | Srwy | $39.6 Bil | |
KVUE
| Kenvue Inc | Jcgbhlm | Wzlht | $36.0 Bil | |
CHD
| Church & Dwight Co Inc | Gywgmrmn | Wkwp | $26.3 Bil | |
CLX
| Clorox Co | Tsqwttlrm | Cdyv | $18.4 Bil | |
COTY
| Coty Inc Class A | Bqk | Mkjs | $10.2 Bil |